Prevalence of Psychiatric Disorders During Pregnancy at 2nd Trimester Ultrasound: a Feasibility Study in the General Population

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

140 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-04-25

Study Completion Date

2026-10-24

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Young women represent a population at risk of psychiatric disorders, the first signs of which often appear between the ages of 15 and 25. Psychiatric disorders are a major source of disability and healthcare costs.

The perinatal period is an additional period of psychological vulnerability, during which women are at increased risk of developing or worsening psychiatric disorders. Unfortunately, psychiatric disorders seem to be largely under-diagnosed during this period, and therefore under-treated.

The goal of this Prospective multicenter study is to determine the prevalence of the presence of at least one characterized psychiatric disorder, as defined by the use of the Mini International Neuropsychiatric Interview (MINI), in remission or not, during pregnancy, at the time of the second-trimester ultrasound (T2 ultrasound) based on a standardized clinical assessment.

Participants will complete self-questionnaires and have a standardized psychiatric evaluation at T2 ultrasound and at 2 months postpartum.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Description of the Psychiatric Care Pathway of Pregnant Women After the Early Prenatal Interview

NCT04574986

Psychiatric Disorder

COMPLETED

Perinatal Thymic DYsregulation: Characterization of Perinatal Mood Episodes

NCT07008183

Perinatal Mental Health

RECRUITING NA

Screening for Depression and Anxiety in Pregnant and Postpartum Women: Evaluating Prevalence, Risk Factors, and the Stepped Screening Protocol in a Care Pathway

NCT06664593

Depression, Postpartum Puerperal Disorders Depression During Pregnancy +4 more

COMPLETED

Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic

NCT04377412

Anxiety Depression Pregnancy Related

UNKNOWN

Genetic Risk Factors Predictive of the Occurrence of Maternally Diagnosed Perinatal Depression in Women

NCT05175755

Perinatal Depression

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Young women represent a population at risk of psychiatric disorders, the first signs of which often appear between the ages of 15 and 25. Psychiatric disorders are a major source of disability and healthcare costs. They are often comorbid, and can be complicated by suicidal behaviour. Delays in diagnosis are common, significantly worsening the prognosis and increasing the societal cost of these disorders.

The perinatal period is an additional period of psychological vulnerability, during which women are at increased risk of developing or worsening psychiatric disorders. Unfortunately, these disorders seem to be largely under-diagnosed during this period, and therefore under-treated.

To date, psychiatric diagnoses are exclusively clinical. They can be facilitated by screening questionnaires, the sensitivity and specificity of which are highly heterogeneous and sometimes poorly understood in the perinatal period and in the general population of pregnant women. What's more, several studies have shown that clinical diagnosis in everyday practice often lacks sensitivity when compared with standardized assessments, i.e. those based on a structured and reproducible diagnostic approach, which is longer and more costly, such as the MINI (Mini International Neuropsychiatric Interview).

The state of knowledge on the epidemiology of psychiatric disorders in the perinatal period suffers from many imperfections. The vast majority of studies focus exclusively on postpartum depression. This project, on the other hand, focuses on the diagnosis of any psychiatric disorder characterized by a standardized diagnostic interview (validated and reproducible, like the MINI) carried out by a professional trained in the clinical management of psychiatric disorders.

Biomarkers, in particular to aid differential diagnosis, are being developed and are a source of hope for improving the quality of screening; but the results are rarely replicated in independent cohorts or from biological banks associated with quality clinical data.

Our hypothesis is that the prevalence of psychiatric disorders (current or in remission), in this population, is at least 20% and that more than half of these disorders are unknown.

From a practical point of view, it aims to improve assessments of psychiatric vulnerabilities within the two main public maternity hospitals in the Hérault department in France.

From a scientific point of view, it will provide an opportunity to create a highly original bank of biological samples, opening up interesting research prospects in psychiatry, but also well beyond, given the specific nature of the population concerned.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pregnancy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pregnant adults

Adults women with an ongoing pregnancy who are scheduled for a T2 ultrasound, regardless of known history or pregnancy context (normal or pathological).

Group Type EXPERIMENTAL

standardized clinical psychiatric evaluations

Intervention Type DIAGNOSTIC_TEST

The intervention consists of a psychiatric consultation including :

* assessment of psychiatric disorders using a MINI test
* information gathering (medical, obstetrical and family history, expected term of pregnancy).
* assessment of suicidal behaviour using the Columbia-Suicide Severity Rating Scale (CSSR-S)
* collection of negative life events over the past 12 months, assessed using the Paykel questionnaire

self-administered psychiatric questionnaire assessments

Intervention Type DIAGNOSTIC_TEST

* EPICES Score: (Evaluation de la Précarité et des Inégalités de santé dans les Centres d'Examens de Santé):
* MIBS: (Mother to Infant Bonding Scale)
* PAI: (Prenatal Attachment Inventory)
* EDEQ: (Eating Disorder Examination Questionnaire)
* PCL-5: (Post-traumatic Stress Disorder Checklist for DSM-V)
* MARS: (Medication Adherence Rating Scale)
* EPDS: (Edinburgh Postnatal Depression Scale)

blood sampling

Intervention Type OTHER

A blood sample is taken to form an optional biological collection, comprising 3 samples:

* A tube to collect RNA from whole blood.
* A tube to collect serum
* A tube to collect native DNA

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

standardized clinical psychiatric evaluations

The intervention consists of a psychiatric consultation including :

* assessment of psychiatric disorders using a MINI test
* information gathering (medical, obstetrical and family history, expected term of pregnancy).
* assessment of suicidal behaviour using the Columbia-Suicide Severity Rating Scale (CSSR-S)
* collection of negative life events over the past 12 months, assessed using the Paykel questionnaire

Intervention Type DIAGNOSTIC_TEST

self-administered psychiatric questionnaire assessments

* EPICES Score: (Evaluation de la Précarité et des Inégalités de santé dans les Centres d'Examens de Santé):
* MIBS: (Mother to Infant Bonding Scale)
* PAI: (Prenatal Attachment Inventory)
* EDEQ: (Eating Disorder Examination Questionnaire)
* PCL-5: (Post-traumatic Stress Disorder Checklist for DSM-V)
* MARS: (Medication Adherence Rating Scale)
* EPDS: (Edinburgh Postnatal Depression Scale)

Intervention Type DIAGNOSTIC_TEST

blood sampling

A blood sample is taken to form an optional biological collection, comprising 3 samples:

* A tube to collect RNA from whole blood.
* A tube to collect serum
* A tube to collect native DNA

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women
* 18 years and over
* Pregnant and consulting for scheduled second trimester ultrasound
* Able to read and write with a good knowledge of French

Exclusion Criteria

* Unable to understand French
* Illiterate
* Underage patient at time of second trimester ultrasound
* Patient under guardianship or curatorship
* Patient deprived of liberty
* Patient not affiliated to or not benefiting from a social security scheme
* Refusal of consent after information
* Participant in another research project with an ongoing exclusion period

Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes